Watching Brief

Date of first report of the outbreak

In Pakistan, first reports of wild poliovirus type 1 (WPV1) emerged on November 02, 2023 ( 1 ), while in Afghanistan, first reports of WPV1 emerged on May 13, 2023 ( 2 ).

Disease or outbreak Disease is unspecified poliomyelitis in two clusters, with the Pakistani cluster confirmed as genetically linked to the earlier-emerged Afghan cluster ( 1 ).
Origin (country, city, region)

Afghanistan and Pakistan.

Suspected Source (specify food source, zoonotic or human origin or other)

Humans are the only reservoir of poliovirus (either wildtype or vaccine-derived) with no identified vector or confirmed cases in other animals ( 3 ).

Date of outbreak beginning

In Pakistan, reports emerged in November 2023, whereas in Afghanistan, reports emerged in May 2023 ( 1 , 2 ).

Date outbreak declared over

Outbreaks are ongoing as of November 2023 ( 1 ).

Affected countries & regions

Wild type poliovirus is currently endemic in two nations, Afghanistan and Pakistan, while vaccine-derived poliovirus is currently experiencing an increase in incidence in multiple nations ( 4 , 5 ).

Number of cases (specify at what date if ongoing)

As of September 2023, 5 cases of WPV1 have been detected in Afghanistan ( 2 ), meanwhile, Pakistan has reported 5 cases of WPV1 year-to-date (2023) ( 2 ). As of November 2023, these numbers are stable.

Clinical features

The incubation period for non-paralytic symptoms ranges from just 3 to 6 days though can commonly extend up to 35 days, while if paralysis is to occur, weakness and then paralysis will onset between 7 and 21 days following successful infection in the oropharynx or gastrointestinal tract (though it has been noted to occur within hours of an infection as well)( 5 - 7 ). Up to 90% of all infected individuals are asymptomatic or experience mild non-specific symptoms (Table 1) ( 5 ).

Table 1: Initial symptoms of poliomyelitis infection ( 5 )

 Fever  Fatigue
 Headache  Emesis
 Stiffness in the neck  Pain in limbs and extremities

Initial symptomology persists for between 2 and 10 days, and recovery is usually complete for many cases ( 5 ). However, paralysis can occur in a small proportion of cases and often begins in the legs. If this does occur, paralysis may be permanent ( 5 ). The more severe the acute phase of the infection, the greater the likelihood of lifelong deficits and permanent paralysis ( 8 ). The non-specific initial presentation of infection can present differential diagnoses such as enteroviruses A71 and D68, both of which cause acute flaccid paralysis, as well as rabies, and syndromes such as Guillain-Barre ( 8 , 9 ).

Mode of transmission (dominant mode and other documented modes)

Wildtype poliovirus (WPV) is transmitted predominantly through the faecal-oral route, and, less commonly, through a common shared vehicle (such as contaminated food or water sources) ( 10 ). Poliovirus can be quickly transmitted in areas with low vaccination rates, poor hygiene practices and inadequate sanitation infrastructure ( 4 , 5 ).

Demographics of cases

All cases are confirmed in children, with an age range of at least 2.5 years to 6 years ( 1 , 2 ). At least one case is confirmed to have permanent paralysis, and no fatalities are currently recorded. Other demographic information is currently unavailable, though geographic information has been ascertained. In Afghanistan, the cluster is centred in several different districts of Nangarhar province, which shares an international border with the refugee-hosting Pakistani province of Kyber Pakhtunkhwa (701,358 Afghan refugees) ( 11 ). The cluster in Pakistan though is located in Sindh province, which is significantly removed from the Afghani border and hosts a far smaller Afghan refugee population (73,789) (11). How these clusters are genetically and epidemiologically linked are key unanswered questions.

Case fatality rate

Traditional outbreaks of poliomyelitis will result in a case fatality range ranging from 5% to 10% in those who are paralysed (asphyxiation occurs when the breathing muscles are paralysed and cease functioning) (5).

Complications

The current geopolitical context, as well as the effects of reduced access and reduced quality of sanitation and hygiene services (4), complicate active and passive surveillance as well as case identification.

If the infection enters the central nervous system and replicates within motor neurons, paralytic poliomyelitis may ensue ( 12). Permanent paralysis is dependent on the degree and extent of motor neurons infected. The typical clinical manifestation of paralytic poliomyelitis is acute flaccid paralysis (AFP), which usually affects the legs, though can affect other limbs as well ( 12 ). Long-term sequelae can include persistent paralysis and deformity of affected limbs. Joint contracture around paralysed muscles can also be experienced, resulting in further complications ( 8 ).

Available prevention

A number of preventative measures exist for poliovirus eradication and generally encompass improving water sources, creating and encouraging effective sanitation practices ( 1), and educating communities on hygiene practices.1 Additionally, robust and comprehensive surveillance programs are seen as key to detecting viral particles in the environment ( 13). Any detection in the environment or through laboratory confirmation of vaccine-derived poliovirus (Type 2) should trigger a thorough outbreak investigation alongside a localised vaccination campaign ( 14). The cornerstone of preventative therapy is the administration of vaccines: oral polio vaccine (OPV), a live attenuated vaccine, and an inactivated polio vaccine (IPV) (4).

The OPV is highly effective in inducing humoral immunity and when compared to the IPV has significant health system advantages in terms of ease of administration, low cost per dose, and efficacy (4). Despite these advantages, individuals administered the OPV can shed the virus in faeces for up to six weeks following the dose (and potentially up to several years if they are immunocompromised) (6). To counter this, the World Health Organisation’s vaccine schedule for both Pakistan and Afghanistan indicate that the vaccine should be administered at birth, six weeks, ten weeks, and fourteen weeks (15,16).

However, as noted in literature and practice, if viral particles are allowed to be shed and circulated, the vaccine virus has a high chance of mutating and developing sufficient transmissibility and neurovirulence to cause symptoms of paralysis (4). To achieve eradication of polio (including vaccine-associated paralytic polio), use of OPV must eventually be ceased globally and replaced with IPV (12).

Available treatment

There is no approved antiviral medication for poliomyelitis. Rather, treatment is supportive and encompasses a range of measures (Table 2) which are specific to the stage of the infection (8).

Table 2: Supportive treatment for acute and convalescent phase of poliomyelitis infection

 Acute Phase Supportive Measures  Convalescent Phase Supportive Measures
 Management of fever  Supportive osteopathic and physiotherapeutic exercises to regain use of paralysed limbs
 Surveillance of and management for respiratory tract infections  Use of orthoses for all previously paralysed limbs
 Mechanical ventilation for respiratory paralysis  
 Splints to relieve myalgia and spasm in legs  
Comparison with past outbreaks

The WHO has a target for eradication of polio. Whilst most of the world has eliminated polio, Pakistan and Afghanistan remain hot spots for wild polio (1,2). In line with a recent descriptive analysis (4), the current clusters are in children. There are likely a far greater number of asymptomatic or mildly symptomatic infections that have not been detected. The minimum age reported in the descriptive analysis was 2 months, while the maximum was 13 years, with a median of 2.3 years. These figures align well to the confirmed age range of the clusters (2.5 years to 6 years) (1,2).The current outbreaks are in areas with low gross domestic product per capita, a low adult literacy rate, and high levels of conflict, all of which contribute to reduced vaccine coverage in these areas (4,12,17).

Unusual features

The most unusual feature of these clusters is the geographical distance between them, some 1,569km.

Figure 1 

Provincial capitals of Nangarhar province (Jalalabad), Kyber Pakhtunkhwa province (Abbottabad), and Sindh province (Karachi) as well as Peshawar (last recorded outbreak of unspecified poliomyelitis in an Afghan refugee camp in Pakistan)

The geographical distance required to transit in a destination nation for displaced Afghan populations seems beyond the means of refugees. A comprehensive review of Afghan refugee health status in camps in Pakistan revealed that as many as 48.05% of all refugees experienced a respiratory tract infection (which could be an early signal of non-specific presenting early stage infection); children receiving all four recommended doses of the OPV has reduced by approximately two-thirds over the last decade; and 19 confirmed cases of poliomyelitis (unspecified) were recorded in a camp in Peshawar, Kyber Pakhtunkhwa, Pakistan in 2015 (note that Peshawar is approximately 114km from the Nangarhar-Kyber Pakhtunkhwa border) (18).

How the clusters are genetically linked is not adequately explained or investigated in detail by either governmental or non-governmental sources, and it could indicate undetected forward transmission in vulnerable populations from unexpected sources, exposing those populations, all workers with Afghan refugees (paid, volunteer, governmental, non-governmental), and local Pakistani communities. A high proportion of undetected asymptomatic cases are likely and may be an epidemiological link.

Critical analysis

Afghanistan faces significant challenges to its health system when attempting to implement an effective, robust, and routine polio vaccination campaign. Geographically, it is estimated that up to 74% of the total population live in rural areas where basic health-care services and vaccination services are not readily available, presenting a significant access barrier (19).

Afghanistan is also facing a backlog of missed vaccinations where it is estimated that up to 3.4 million children missed routine vaccinations in 2018 alone (19). Since then, the Afghanistan Polio Eradication Initiative (PEI) has struggled to achieved vaccination targets month-on-month, further exacerbating reducing vaccine coverage (20). Interestingly, the PEI reported a 100% vaccine coverage in Nangarhar province in both 2020 and 2021 (20) – the emergence of a cluster throughout the province indicates coverage is clearly not universal, or an infectious but asymptomatic carrier was introduced to susceptible and immunologically naïve populations and further investigation is warranted to determine causality and incorporate this event into PEI’s strategic planning.

The major concern is health worker security (19, 20 ). The PEI reported in 2021 nine confirmed health worker deaths, and four seriously injured health workers in Nangarhar. Additionally, Kyber Pakhtunkhwa also reported the deaths of policemen providing security to health care workers in 2021, while the Kandahar-Afghan border crossing reported one death of a health worker, and the Balochistan-Afghan border region recorded the abduction of a vaccination team (21,22). The Taliban, pushed to Pakistan during the American-led invasion and occupation of Afghanistan, responded negatively to the continued occupation, and banned the OPV from being received from non-Islamic sources and from women of any religion in Taliban-controlled regions of both Afghanistan and Pakistan – notably the border regions where health worker security was least enforced (21). The Taliban initiated targeted executions of health workers, and improvised explosive devices targeting vaccination convoys resulting in governmental and non-governmental partners ceasing vaccination efforts in an attempt to protect health workers (21).

This strong resistance to vaccination is more than expected for typical vaccine hesitancy and can be traced back to the United States’ Central Intelligence Agency’s (CIA) covert program of surveillance to locate Osama bin Laden ( 23 ). Extensive local investigations revealed that a senior Pakistani doctor was employed by a CIA-supported shell company to administer hepatitis B vaccines in (24) areas identified by drone footage as being likely to be the residence of Osama bin Laden or his family (24). This program was started in Abbottabad, the capital of Kyber Pakhtunkhwa province, with local residences who received the first dose confirming that follow-up doses were not administered by the program ( 24). The program did gain access to the compound that ultimately contained Osama bin Laden, which enabled the CIA to plan the raid on the compound and execute Osama bin Laden ( 23 ). This program was in conjunction with the repeated incursions and drone strikes into Afghan and Pakistani border regions by United States forces occurring from 2004 ( 23 ), which only served to unite Al-Qaeda and Taliban forces against any ‘Western’ supported initiative and directly jeopardised the safety of health workers. It is clear that any vaccination effort therefore faces significant and widespread challenges to legitimacy and utility.

The PEI claim a national refusal rate of the OPV of just 1%, rising to 3% in tribal areas ( 20 ). With clear evidence of targeted hostility, coordinated cross-border attacks, ongoing security threats from two groups, the propagative epidemic curve of cases in Afghanistan and Pakistan, a failure by the PEI to achieve vaccination targets, and continuing accessibility issues, this refusal rate is potentially under-reported and adds to an extremely complex and sensitive geopolitical situation. Further complicating this is the ongoing trending increase in positive environmental samples – such programs require consistency, laboratory confirmation, and linkage with epidemiological services and the security of those involved in these programs is currently not known ( 25 ) With the Taliban recently permitting vaccination efforts to resume following a ban in 2018, security concerns are potentially addressed, but the geopolitical situation warrants further surveillance, investigation, education, and support to achieve control and eradication ( 26 )

Key questions

1. Is there an epidemiological link or travel history between the cluster in Nangarhar province, Afghanistan and Sind province, Pakistan?

2. Are there any epidemiological or geographical links between the Afghan refugee camps in Kyber Pakhtunkhwa and Sindh provinces in Pakistan?

3. What security precautions are currently in place before a vaccination campaign?

References

1. Mbaeyi C BS, Safdar RM, et al. Progress toward poliomyelitis eradication—Pakistan, January 2022–June 2023. MMWR Morb Mortal Wkly Rep 2023;72:880–885. 2023;72.

2. Bjork A AI, Chaudhury S, et al. Progress Toward Poliomyelitis Eradication—Afghanistan, January 2022–June 2023. MMWR Morb Mortal Wkly Rep 2023;72:1020–1026. 2023;72.

3. Centers for Disease Control and Prevention. Poliomyelitis: Clinical Presentation: Centers for Disease Control and Prevention(United States); 2022 [Available from: https://www.cdc.gov/polio/us/hcp/clinical-presentation.html.

4. Lai YA, Chen X, Kunasekaran M, Rahman B, MacIntyre CRJE. Global epidemiology of vaccine-derived poliovirus 2016–2021: a descriptive analysis and retrospective case-control study. 2022;50.

5. World Health Organization. Poliomyelitis (polio) World Health Organization (Switzerland); 2023 [Available from: https://www.who.int/health-topics/poliomyelitis/#tab=tab_1.

6. Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Expert review on poliovirus immunity and transmission. 2013;33(4):544-605.

7. Australian Government Department of Health and Aged Care. Poliomyelitis: Australian Government Department of Health and Aged Care (Australia); 2023 [Available from: https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/poliomyelitis.

8. Wolbert JG HKP. Poliomyelitis: StatPearls; 2023 [Available from: https://www.ncbi.nlm.nih.gov/books/NBK558944/.

9. Minor PD. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication. Methods Mol Biol. 2016;1387:1-10.

10. Razum O, Sridhar D, Jahn A, Zaidi S, Ooms G, Müller OJBgh. Polio: from eradication to systematic, sustained control. 2019;4(4):e001633.

11. United Nations High Commissioner for Refugees. Afghan refugees in pakistan by province 2023 [Available from: https://data.unhcr.org/en/country/pak.

12. World Health Organization. Polio vaccines: WHO position paper, January 2014: World Health Organization (Switzerland); 2014 [Available from: https://iris.who.int/bitstream/handle/10665/242183/WER8909_73-92.PDF?isAllowed=y&sequence=1.

13. European Centre for Disease Prevention and Control. Prevention and control measures for poliomyelitis: European Centre for Disease Prevention and Control, Sweden; 2018 [Available from: https://www.ecdc.europa.eu/en/poliomyelitis/prevention-and-control.

14. Balkhy HHJMM, Report MW. Notes from the field: nosocomial outbreak of Middle East respiratory syndrome in a large tertiary care hospital—Riyadh, Saudi Arabia, 2015. 2016;65.

15. World Health Organization Eastern Mediterranean Region. Pakistan Expanded Programme on Immunization 2024 [Available from: https://www.emro.who.int/pak/programmes/expanded-programme-on-immunization.html.

16. Mugali RR, Mansoor F, Parwiz S, Ahmad F, Safi N, Higgins-Steele A, et al. Improving immunization in Afghanistan: results from a cross-sectional community-based survey to assess routine immunization coverage. 2017;17:1-9.

17. The World Bank. Afghanistan: Province Dashboard: The World Bank (Washington DC); 2019 [Available from: https://www.worldbank.org/en/data/interactive/2019/08/01/afghanistan-interactive-province-level-visualization.

18. The United States Agency for International Development. Provincial Fact Sheet- Sindh: The United States Agency for International Development (Washington DC); 2018 [Available from: https://www.usaid.gov/pakistan/fact-sheet/provincial-fact-sheet-sindh.

19. Malik MS, Afzal M, Farid A, Khan FU, Mirza B, Waheed MTJFiPH. Disease status of Afghan refugees and migrants in Pakistan. 2019;7:185.

20. Tharwani ZH, Shaeen SK, Arshad MS, Khalid MA, Islam Z, Nemat A, et al. Polio amid a humanitarian crisis in Afghanistan: challenges and recommendations. The Lancet Infectious Diseases. 2022;22(2):168-9.

21. GEO News. Two policemen guarding polio workers killed in Kyber Pakhtunkhwa.: GEO News (Pakistan); 2021 [Available from: https://www.geo.tv/latest/363034-two-policemen-guarding-polio-workers-killed-in-khyber-pakhtunkhwa.

22. Gul S AS, Aziz S, . AFGHANISTAN POLIO ERADICATION INITIATIVE ANNUAL REPORT 2021: Polio Eradication Initiative (Afghanista); 2021 [Available from: https://polioeradication.org/wp-content/uploads/2022/06/Afghanistan-Annual-Report-2021.pdf.

23. The Guardian. CIA organised fake vaccination drive to get Osama bin Laden's family DNA: The Guardian (Internet); 2011 [Available from: https://www.theguardian.com/world/2011/jul/11/cia-fake-vaccinations-osama-bin-ladens-dna.

24. McGirk T MJ. How the Bin Laden Raid Put Vaccinators Under the Gun in Pakistan: NATIONAL GEOGRAPHIC (Pakistan); 2015 [Available from: https://pulitzercenter.org/stories/how-bin-laden-raid-put-vaccinators-under-gun-pakistan.

25. Crews RD, Tarzi A. The Taliban and the crisis of Afghanistan: Harvard University Press; 2009.

26. News UN. Taliban backs WHO polio vaccination campaign across Afghanistan next month: United Nations News (United States); 2021 [Available from: https://news.un.org/en/story/2021/10/1103322.